Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh

Pyrazinamide (PZA) is a frontline antituberculosis (anti-TB) drug used in both first- and second-line treatment regimens. However, due to complex laboratory requirements, the PZA susceptibility test is rarely performed, leading to a scarcity of data on susceptibility to PZA. Bangladesh is a country...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Rahman, Arfatur, Ferdous, Sara Sabrina, Ahmed, Shahriar, Rahman, S. M. Mazidur, Uddin, Mohammad Khaja Mafij, Pholwat, Suporn, Gratz, Jean, Houpt, Eric, Banu, Sayera
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571327/
https://ncbi.nlm.nih.gov/pubmed/28630193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00511-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados